TY - JOUR
T1 - Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype
AU - Smith, Justin S.
AU - Alderete, Benjamin
AU - Minn, Yuriko
AU - Borell, Thomas J.
AU - Perry, Arie
AU - Mohapatra, Gayatry
AU - Hosek, Sandra M.
AU - Kimmel, David
AU - O'Fallon, Judith
AU - Yates, Allan
AU - Feuerstein, Burt G.
AU - Burger, Peter C.
AU - Scheithauer, Bernd W.
AU - Jenkins, Robert B.
N1 - Funding Information:
PCR primers for the AKT2 gene were designed using sequence generously provided by Dr Joseph Testa (Fox Chase Cancer Center, Philadelphia, PA, USA). This work was supported by NIH grants: CA50905 (D Kimmel, J O'Fallon, BW Scheithauer, RB Jenkins), CA50910 (A Yates), CA64898 (BG Feuerstein), CA61147 (BG Feuer-stein), CA64928 (PC Burger), and by The American Brain Tumor Foundation (A Perry). Justin Smith is supported by the Sidney Luckman Endowed Physician Scientist Scholarship.
PY - 1999/7/15
Y1 - 1999/7/15
N2 - Allelic alterations of chromosomes 1 and 19 are frequent events in human diffuse gliomas and have recently proven to be strong predictors of chemotherapeutic response and prolonged survival in oligodendrogliomas. Using 115 human diffuse gliomas, we localized regions of common allelic loss on chromosomes 1 and 19 and assessed the association of these deletion intervals with glioma histological subtypes. Further, we evaluated the capacity of multiple modalities to detect these alterations, including loss of heterozygosity (LOH), fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH). The correlation coefficients for detection of 1p and 19q alterations, respectively, between modalities were: 0.98 and 0.87 for LOH and FISH, 0.79 and 0.60 for LOH and CGH, and 0.79 and 0.53 for FISH and CGH. Minimal deletion regions were defined on 19q13.3 (D19S412-D19S596) and 1p (D1S468-D1S1612). Loss of the 1p36 region was found in 18% of astrocytomas (10/55) and in 73% (24/33) of oligodendrogliomas (P < 0.0001), and loss of the 19q13.3 region was found in 38% (21/55) of astrocytomas and 73% (24/33) of oligodendrogliomas (P = 0.0017). Loss of both regions was found in 11% (6/55) of astrocytomas and in 64% (21/33) of oligodendrogliomas (P < 0.0001). All gliomas with LOH on either 1p or 19q demonstrated loss of the corresponding FISH probe, 1p36 or 19q13.3, suggesting not only locations of putative tumor suppressor genes, but also a simple assay for assessment of 1p and 19q alterations as diagnostic and prognostic markers.
AB - Allelic alterations of chromosomes 1 and 19 are frequent events in human diffuse gliomas and have recently proven to be strong predictors of chemotherapeutic response and prolonged survival in oligodendrogliomas. Using 115 human diffuse gliomas, we localized regions of common allelic loss on chromosomes 1 and 19 and assessed the association of these deletion intervals with glioma histological subtypes. Further, we evaluated the capacity of multiple modalities to detect these alterations, including loss of heterozygosity (LOH), fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH). The correlation coefficients for detection of 1p and 19q alterations, respectively, between modalities were: 0.98 and 0.87 for LOH and FISH, 0.79 and 0.60 for LOH and CGH, and 0.79 and 0.53 for FISH and CGH. Minimal deletion regions were defined on 19q13.3 (D19S412-D19S596) and 1p (D1S468-D1S1612). Loss of the 1p36 region was found in 18% of astrocytomas (10/55) and in 73% (24/33) of oligodendrogliomas (P < 0.0001), and loss of the 19q13.3 region was found in 38% (21/55) of astrocytomas and 73% (24/33) of oligodendrogliomas (P = 0.0017). Loss of both regions was found in 11% (6/55) of astrocytomas and in 64% (21/33) of oligodendrogliomas (P < 0.0001). All gliomas with LOH on either 1p or 19q demonstrated loss of the corresponding FISH probe, 1p36 or 19q13.3, suggesting not only locations of putative tumor suppressor genes, but also a simple assay for assessment of 1p and 19q alterations as diagnostic and prognostic markers.
KW - Chromosome 1
KW - Chromosome 19
KW - Comparative genomic hybridization
KW - Diffuse glioma
KW - Fluorescence in situ hybridization
KW - Loss of heterozygosity
KW - Tumor suppressor gene
UR - http://www.scopus.com/inward/record.url?scp=0033566061&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033566061&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1202759
DO - 10.1038/sj.onc.1202759
M3 - Article
C2 - 10435596
AN - SCOPUS:0033566061
SN - 0950-9232
VL - 18
SP - 4144
EP - 4152
JO - Oncogene
JF - Oncogene
IS - 28
ER -